Tu sei qui: Home > CANNABINOIDS

CANNABINOIDS

The Journal of the International Association for Cannabinoid Medicines

Case report

Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child

René Kurz, Kurt Blaas
Cannabinoids 2010;5(4):4-6 (21 November 2010)


[ Riassunto ] [ PDF del testo completo ]

Review

Review on clinical studies with cannabis and cannabinoids 2005-2009

Arno Hazekamp, Franjo Grotenhermen
Cannabinoids 2010;5(special issue):1-21 (February 13, 2010)


[ Riassunto ] [ PDF del testo completo ]

Article of the Month

Cannabinoids in cancer pain

Franjo Grotenhermen
Cannabinoids 2010;5(1):1-3 (January 23, 2010)


[ Riassunto ] [ PDF del testo completo ]

Article of the Month

The endocannabinoid 2-arachidonoylglycerol promotes sperm developement through activation of cannabinoid-2 receptors

Mauro Maccarrone
Cannabinoids 2009;4(4):4-6 (December 19, 2009)


[ Riassunto ] [ PDF del testo completo ]

Article of the Month

THC can improve symptoms of schizophrenia

Franjo Grotenhermen
Cannabinoids 2009;4(4):1-3 (November 21, 2009)


[ Riassunto ] [ PDF del testo completo ]

Mini-review

Adulteration of cannabis with tobacco, calamus, and other cholinergic compounds

John M. McPartland
Cannabinoids 2008;3(4):16-20 (21 December 2008)


[ Riassunto ] [ PDF del testo completo ]

Mini-review

Cannabinoids and schizophrenia: where is the link?

Kirsten Müller-Vahl
Cannabinoids 2008;3(4):11-14 (9 November 2008)


[ Riassunto ] [ PDF del testo completo ]

Original article

Treating depression with cannabinoids

Kurt Blaas
Cannabinoids 2008;3(2):8-10 (22 June 2008)


[ Riassunto ] [ PDF del testo completo ]

Mini-review

Animal research highlights a therapeutic potential of cannabinoids for the treatment of depression

Regina A. Mangieri
Cannabinoids 2008;3(2):4-7 (22 June 2008)


[ Riassunto ] [ PDF del testo completo ]

Case report

Cannabis improves symptoms of ADHD

Peter Strohbeck-Kuehner, Gisela Skopp, Rainer Mattern
Cannabinoids 2008;3(1):1-3 (2 March 2008)


[ Riassunto ] [ PDF del testo completo ]

Letter to the Editor

Letter: Rewarding effects of drug abuse?

Franjo Grotenhermen
Cannabinoids 2007;2(4):27 (28 October 2007)


[ Riassunto ] [ PDF del testo completo ]

Original article

An endocannabinoid hypothesis of drug reward

Emmanuel S. Onaivi
Cannabinoids 2007;2(3):22-26 (30 September 2007)


[ Riassunto ] [ PDF del testo completo ]

Letter to the editor

Letter: The herbal way - a response to Ethan Russo

Arno Hazekamp
Cannabinoids 2007;2(3):20-21 (2 September 2007)


[ Riassunto ] [ PDF del testo completo ]

Letter to the editor

Letter: Cannabinoid medicines and the need for the scientific method

Ethan B. Russo
Cannabinoids 2007;2(2):16-19 (13 May 2007)


[ Riassunto ] [ PDF del testo completo ]

Thesis

On the future of cannabis as medicine

Lester Grinspoon
Cannabinoids 2007;2(2):13-15 (13 May 2007)


[ Riassunto ] [ PDF del testo completo ]

Letter to the Editor

Letter: Preclinical assessment of abuse liability of ajulemic acid

Jenny L. Wiley
Cannabinoids 2007;2(1):3-4 (21 January 2007)


[ Riassunto ] [ PDF del testo completo ]

Comment

In humans, ajulemic acid has a more favorable side-effect profile than THC for the treatment of chronic neuropathic pain

Sumner H. Burstein
Cannabinoids 2007;2(1):1-2 (21 January 2007)


[ Riassunto ] [ PDF del testo completo ]

Mini-review

The endogenous cannabinoid system: a new player in the brain-gut-adipose axis

Ester Fride
Cannabinoids 2006;2(2):5-12 (15 April 2007)


[ Riassunto ] [ PDF del testo completo ]

Mini-review

Cannabinoids: potential antitumoral agents?

Manuel Guzmán
Cannabinoids 2006;1(2):15-17 (10 December 2006)


[ Riassunto ] [ PDF del testo completo ]

Mini-review

Cannabinoids and the Endocannabinoid System

Franjo Grotenhermen
Cannabinoids 2006;1(1):10-14 (17 September 2006))


[ Riassunto ] [ PDF del testo completo ]

Original article

An evaluation of the quality of medicinal grade cannabis in the Netherlands

Arno Hazekamp
Cannabinoids 2006;1(1):1-9 (13 August 2006)


[ Riassunto ] [ PDF del testo completo ]

Webinar 2020

Nell'ottobre 2020 l'IACM organizza una serie di webinar. Tra i relatori ci sono Roger Pertwee, Raphael Mechulam, Manuel Guzman, Ethan Russo e Kirsten Müller-Vahl. Dopo i webinar ci saranno sottotitoli per diverse lingue. L'accesso è gratuito per gli utenti abituali dell'IACM. Qui trovate l'opuscolo per gli sponsor. Qui trovate informazioni sulle tariffe di registrazione e un link per la registrazione.

Conferenza IACM 2020

L'IACM terrà la sua 11° Conferenza sui cannabinoidi in medicina in collaborazione con l'Asociación Mexicana de Medicina Cannabinodie dal 5 al 7 novembre 2020 a Città del Messico. Sarà un congresso virtuale. Qui trovate informazioni sulle tariffe di registrazione e un link per la registrazione.

Conferenza IACM 2021

La dodicesima conferenza IACM sui cannabinoidi in medicina si terrà a Basilea, in Svizzera, dal 14 al 16 ottobre 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.